Details for New Drug Application (NDA): 202805
✉ Email this page to a colleague
The generic ingredient in GRISEOFULVIN, ULTRAMICROSIZE is griseofulvin, ultramicrosize. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the griseofulvin, ultramicrosize profile page.
Summary for 202805
Tradename: | GRISEOFULVIN, ULTRAMICROSIZE |
Applicant: | Sandoz |
Ingredient: | griseofulvin, ultramicrosize |
Patents: | 0 |
Pharmacology for NDA: 202805
Physiological Effect | Decreased Mitosis Microtubule Inhibition |
Suppliers and Packaging for NDA: 202805
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
GRISEOFULVIN, ULTRAMICROSIZE | griseofulvin, ultramicrosize | TABLET;ORAL | 202805 | ANDA | Sandoz Inc | 0781-5827 | 0781-5827-01 | 100 TABLET, COATED in 1 BOTTLE (0781-5827-01) |
GRISEOFULVIN, ULTRAMICROSIZE | griseofulvin, ultramicrosize | TABLET;ORAL | 202805 | ANDA | Sandoz Inc | 0781-5827 | 0781-5827-05 | 500 TABLET, COATED in 1 BOTTLE (0781-5827-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 125MG | ||||
Approval Date: | Dec 26, 2018 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
Approval Date: | Dec 26, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription